Unraveling the Impact of Per- and Polyfluoroalkyl Substances on Early Kidney Injury in Adolescents with Obesity and Diabetes

揭示全氟烷基和多氟烷基物质对肥胖和糖尿病青少年早期肾损伤的影响

基本信息

  • 批准号:
    10837574
  • 负责人:
  • 金额:
    $ 46.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-27 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY / ABSTRACT: Youth-onset type 2 diabetes (Y-T2D) is a rapidly growing epidemic in the US, with a severe phenotype and limited modifiable risk factors or effective therapies. Climate change, such as extreme heat, and water contamination by per- and polyfluoroalkyl substances (PFAS) are emerging risk factors for Y-T2D development and early diabetic kidney disease. Adolescents with obesity and pre-diabetes may be more susceptible to PFAS's detrimental effects on β-cell and kidney function due to their developing physiology and increased vulnerability to environmental stressors, including extreme heat. In response to NOT-HD-23-006, we propose an administrative supplement to R01 DK129211 for a first-of-its- kind transdisciplinary study to address knowledge gaps by examining the impact of PFAS exposure and heat waves on β-cell and kidney function during puberty in adolescents with obesity and pre-diabetes. We aim to investigate associations between individual PFAS and PFAS mixtures with β-cell and kidney injury during puberty, and examine whether heat waves modify the relationship between PFAS exposure and β-cell and kidney injury, hypothesizing that extreme heat intensifies this association. We will quantify PFAS in participants' plasma and residential water samples and determine heat wave exposure using data from the Colorado Climate Center and participants' residential history records. Our second aim is to integrate data on PFAS exposure and heat waves to understand pathways of β-cell and kidney injury, hypothesizing that PFAS exposure, heat waves, and multi-omic signatures associated with β-cell toxicity and kidney injury can predict subgroups of youth at risk of T2D onset and progression, and early kidney disease. We will measure proteomics and metabolomics in plasma and perform Latent Unknown Clustering Integrating multi-omics Data (LUCID) to integrate environmental factors with multi-omic features. These findings have the potential to revolutionize our understanding of environmental factors in Y-T2D, including the role of climate change-related weather events, such as extreme heat exposure, and inform precision medicine strategies for reducing modifiable PFAS exposure early in life, ultimately preventing β-cell and kidney damage and alleviating the burden of Y-T2D.
项目摘要/摘要: 青年起病的2型糖尿病(Y-T2D)在美国是一种迅速增长的流行病,具有严重的表型和 有限的可改变的危险因素或有效的治疗。气候变化,如酷热和水 全氟烷基物质和多氟烷基物质(PFAS)的污染是Y-T2D发展的新危险因素 和早期糖尿病肾病。患有肥胖和糖尿病前期的青少年可能更容易患上 全氟辛烷磺酸对β细胞和肾功能的不利影响 易受环境应激源的影响,包括酷热。 为了响应NOT-HD-23-006,我们建议对R01 DK129211进行行政补充,以实现ITS- 通过检查全氟辛烷磺酸暴露和高温的影响来解决知识差距的跨学科研究 肥胖和糖尿病前期青少年青春期β细胞和肾功能的波动。我们的目标是 研究单项全氟辛烷磺酸和全氟辛烷磺酸混合物与β细胞和肾脏损伤的关系 青春期,并检查热浪是否改变了PFAS暴露与β细胞和 肾脏损伤,假设极端高温加剧了这种联系。我们将对全氟辛烷磺酸进行量化 参与者的血浆和居民水样,并使用来自 科罗拉多州气候中心和参与者的居住历史记录。 我们的第二个目标是整合关于PFAS暴露和热波的数据,以了解β-CELL和 肾损伤,假设与β细胞相关的PFAS暴露、热浪和多组特征 毒性和肾脏损伤可以预测T2D发病和进展的风险青年亚组以及早期肾脏 疾病。我们将测量血浆中的蛋白质组学和代谢组学,并进行潜在的未知聚类 集成多组学数据(LUID),将环境因素与多组学特征相结合。 这些发现有可能彻底改变我们对Y-T2D中环境因素的理解, 包括与气候变化有关的天气事件的作用,如极端高温暴露,并告知 减少生命早期可改变的PFAS暴露的精准医学策略,最终预防β-细胞 和肾脏损害,减轻Y-T2D的负担。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Petter M Bjornstad其他文献

Petter M Bjornstad的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Petter M Bjornstad', 18)}}的其他基金

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)
1 型糖尿病索马鲁肽对心血管结局的影响 (T1-DISCO)
  • 批准号:
    10672454
  • 财政年份:
    2022
  • 资助金额:
    $ 46.66万
  • 项目类别:
Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort
1 型糖尿病肾脏疾病的发病机制:现代肾活检队列
  • 批准号:
    10627851
  • 财政年份:
    2022
  • 资助金额:
    $ 46.66万
  • 项目类别:
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)
1 型糖尿病索马鲁肽对心血管结局的影响 (T1-DISCO)
  • 批准号:
    10507929
  • 财政年份:
    2022
  • 资助金额:
    $ 46.66万
  • 项目类别:
Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort
1 型糖尿病肾脏疾病的发病机制:现代肾活检队列
  • 批准号:
    10420966
  • 财政年份:
    2022
  • 资助金额:
    $ 46.66万
  • 项目类别:
Measuring metabolically active kidney tissue in autosomal dominant polycystic kidney disease
测量常染色体显性多囊肾病中代谢活跃的肾组织
  • 批准号:
    10281837
  • 财政年份:
    2021
  • 资助金额:
    $ 46.66万
  • 项目类别:
Puberty, diabetes, and the kidneys, when eustress becomes distress
当良性压力变成痛苦时,青春期、糖尿病和肾脏
  • 批准号:
    10654000
  • 财政年份:
    2021
  • 资助金额:
    $ 46.66万
  • 项目类别:
Puberty, diabetes, and the kidneys, when eustress becomes distress
当良性压力变成痛苦时,青春期、糖尿病和肾脏
  • 批准号:
    10272687
  • 财政年份:
    2021
  • 资助金额:
    $ 46.66万
  • 项目类别:
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
肾脏 HEIR 研究:青年发病 2 型糖尿病研究中的肾脏血流动力学、能量学和胰岛素抵抗
  • 批准号:
    9923652
  • 财政年份:
    2018
  • 资助金额:
    $ 46.66万
  • 项目类别:
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
肾脏 HEIR 研究:青年发病 2 型糖尿病研究中的肾脏血流动力学、能量学和胰岛素抵抗
  • 批准号:
    10397016
  • 财政年份:
    2018
  • 资助金额:
    $ 46.66万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 46.66万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.66万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 46.66万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.66万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 46.66万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.66万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 46.66万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 46.66万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 46.66万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.66万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了